Adam Walker’s Pharma Prescribed Podcast

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.

In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?

Today, I’m joined by Sam Usher.

His career began by accident. A place at the National Youth Theatre sparked a fascination with performance that quickly evolved into choreography — the power of expression through the body, communicating emotion without words. He trained at Ballet Rambert and at the Northern School of Contemporary Dance in Leeds before moving to Brussels to perform while simultaneously creating his own work through his company, Feed.

After twelve years in dance, a planned move to Montreal took an unexpected detour to Devon for the summer — where he picked up a camera and never put it down. Film replaced the stage, leading to his first ITV commission: a ski series focused not on spectacle, but on the individuals and preparation behind elite performance. That project took him to Chamonix and marked the start of a new direction.

From mountain couloirs to open water, sailing introduced him to live sport — the closest thing to stage adrenaline. He built a successful production company that ran for fifteen years before the disruption of lockdown forced another reinvention.

Chapter three is rooted in wellbeing: Steam Works — a community-led sauna experience designed around connection, ritual and reset, where Sam and I first met on the beach in South Devon, Bigbury-on-sea.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.

In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?

Duncan Kemp is the founder of Saltware Solutions, a software consultancy firm with a mission to empower life science businesses with innovative and reliable solutions that drive efficiency, enhance productivity, and foster growth. With over 20 years leading the development of software for the life sciences industry, Duncan has translated customer requirements to technical concepts with clarity, so incredible ideas are converted into tangible business benefits.

His journey began in 1998 during university whilst working at a small startup developing site automation software for phase I trials.

Over a period of two decades Duncan navigated several company acquisitions which resulted in leading multiple teams of software engineers across three continents.

In January 2024 that all changed when Duncan was restructured out of his role and decided to make the daunting leap into setting up a business.

In March 2025 Duncan and I met at the Association of Clinical Data Mgt event in the beautiful city of Prague. We struck up a friendship and after an amusing butt-dial have kept in contact ever since.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.

In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?

Tom Farrand has worked throughout his career at the intersection of AI and the life sciences.

First at IBM helping university hospitals to use supercomputers to model 3D heart scans at higher resolutions.

Then he joined leading startups and led the roll out of AI infrastructure for Janssen, Medtronic and Exscientia.

Now as CEO and Co-founder of Delfa he's building AI agents which automate clinical operations, starting in patient recruitment. His mission is clear: to accelerate access to life‑saving treatments by reimagining how patients connect with trials.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.

In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?

Today, I’m joined by Poorya Amini, founder and CEO of Risklick, a Swiss digital health company that’s redefining how clinical trial protocols are designed.

Poorya’s journey spans veterinary medicine, a PhD in pharmacology, and hands‑on experience managing cardiology trials at the University of Bern. In 2019, he launched Risklick to tackle one of pharma’s biggest bottlenecks: protocol inefficiency.

Risklick’s flagship product, Protocol AI™, draws on a database of over 800,000 clinical trials to cut protocol development time by 50%, reduce amendments by 20%, and shorten implementation by 40%.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.

In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?

Anna Maxwell is a mission-driven founder, pharmacist and entrepreneur dedicated to widening access to medicines and empowering people to take more control of their health.

She is the CEO and Founder of Maxwellia, one of the UK’s most ambitious emerging consumer healthcare companies, on a mission to become a Top 50 global challenger brand in self-care.

With more than 30 years’ experience in retail pharmacy, consumer healthcare marketing and commercialising over-the-counter (OTC) medicines, Anna specialises in transforming prescription medicines into trusted, pharmacy-ready brands through the highly regulated process of reclassification.

By unlocking the untapped value of legacy drugs, Maxwellia is creating the blockbuster OTC medicine brands of the future and reshaping how people manage everyday health. 

As a female founder, she has demonstrated what’s possible when purpose and commercial discipline meet relentless ambition